\u00abOlpha\u00bb invest\u012bcijas farm\u0101cijas nozar\u0113 sasniegu\u0161as 4,4 miljonus eiro jaunu ra\u017eo\u0161anas iek\u0101rtu moderniz\u0101cij\u0101<\/p>\n
Z\u0101\u013cu ra\u017eot\u0101js AS “Olpha” ir veicis noz\u012bm\u012bgu soli savas konkur\u0113tsp\u0113jas un ra\u017eo\u0161anas jaudu stiprin\u0101\u0161an\u0101, invest\u0113jot 4,4 miljonus eiro jaunu, modernu medikamentu ra\u017eo\u0161anas iek\u0101rtu ieg\u0101d\u0113 un uzst\u0101d\u012b\u0161an\u0101. \u0160is solis ir ne tikai b\u016btisks solis uz\u0146\u0113muma att\u012bst\u012bb\u0101, bet ar\u012b ieguld\u012bjums Latvijas tautsaimniec\u012bb\u0101, mazinot atkar\u012bbu no z\u0101\u013cu importa un stiprinot viet\u0113jo farm\u0101cijas nozari. \u0160\u012bs invest\u012bcijas apliecina “Olpha” ap\u0146em\u0161anos nodro\u0161in\u0101t augst\u0101k\u0101s kvalit\u0101tes medikamentus un veicin\u0101t inov\u0101cijas farm\u0101cijas sektor\u0101.<\/p>\n
Moderniz\u0101cija un jaudas palielin\u0101\u0161ana<\/p>\n
Uz\u0146\u0113muma veikto ieguld\u012bjumu kl\u0101sts ir pla\u0161s un strat\u0113\u0123iski orient\u0113ts uz ra\u017eo\u0161anas procesu optimiz\u0101ciju un efektivit\u0101tes cel\u0161anu. Starp jaunieg\u0101d\u0101taj\u0101m iek\u0101rt\u0101m ir kompakators, kas ir nepiecie\u0161ams sauso granulu z\u0101\u013cu formu izveidei, \u0161\u012bs iek\u0101rtas v\u0113rt\u012bba ir 356 750 eiro. V\u0113l iespaid\u012bg\u0101ks ieguld\u012bjums ir 800 000 eiro v\u0113rts jaunais table\u0161u apvalko\u0161anas katls, kas \u013cauj uzlabot medikamentu kvalit\u0101ti un ra\u017eo\u0161anas procesus. Papildus tam, 700 000 eiro ir ieguld\u012bti jaunas z\u0101\u013cu kapsul\u0113\u0161anas iek\u0101rtas uzst\u0101d\u012b\u0161an\u0101. \u0160\u012bs invest\u012bcijas kopum\u0101 veido 2,256 miljonus eiro, kas ir b\u016btiska da\u013ca no kop\u0113j\u0101 4,4 miljonu eiro finans\u0113juma. \u0160\u012bs jaun\u0101s iek\u0101rtas dubulto ra\u017eo\u0161anas jaudas \u2013 ja iepriek\u0161 stund\u0101 var\u0113ja sara\u017eot 42 t\u016bksto\u0161us kapsulu, tad nu \u0161is skaitlis ir dubultojies l\u012bdz 84 t\u016bksto\u0161iem. \u0160\u012b efektivit\u0101tes pieauguma nodro\u0161ina ne tikai strauj\u0101ku ra\u017eo\u0161anu, bet ar\u012b \u013cauj apmierin\u0101t pieaugo\u0161o piepras\u012bjumu gan viet\u0113j\u0101, gan starptautiskajos tirgos.<\/p>\n
Valsts atbalsts un ilgtsp\u0113j\u012bgas att\u012bst\u012bbas v\u012bzija<\/p>\n
\u0160\u012b apjom\u012bg\u0101 invest\u012bcija nav tikai pa\u0161a uz\u0146\u0113muma iniciat\u012bva, bet tiek atbalst\u012bta ar\u012b no valsts puses. 30% no iek\u0101rtu ieg\u0101des izmaks\u0101m ir pie\u0161\u0137irts valsts atbalsts, \u012bstenojot programmu “Lielo invest\u012bciju aizdevums ar kapit\u0101la atlaidi” sadarb\u012bb\u0101 ar Latvijas Invest\u012bciju un att\u012bst\u012bbas a\u0123ent\u016bru (LIAA) un AS “Att\u012bst\u012bbas finan\u0161u instit\u016bciju “Altum””. \u0160\u0101da veida sadarb\u012bba starp valsti un uz\u0146\u0113mumiem ir b\u016btiska, lai veicin\u0101tu viet\u0113j\u0101s ra\u017eo\u0161anas att\u012bst\u012bbu un nodro\u0161in\u0101tu Latvijas ekonomikas konkur\u0113tsp\u0113ju pasaules tirg\u016b. Juris Bundulis, AS “Olpha” valdes priek\u0161s\u0113d\u0113t\u0101js, uzsver, ka viena no uz\u0146\u0113muma galvenaj\u0101m priorit\u0101t\u0113m ir veicin\u0101t za\u013c\u0101ku, efekt\u012bv\u0101ku un ilgtsp\u0113j\u012bg\u0101ku ra\u017eo\u0161anas procesu. Papildus tam, darba tirgus situ\u0101cijas d\u0113\u013c arvien liel\u0101ka noz\u012bme ir ra\u017eo\u0161anas un pako\u0161anas darbu automatiz\u0101cijai, kas ir nepiecie\u0161ama, lai nodro\u0161in\u0101tu nepiecie\u0161amos ra\u017eo\u0161anas apjomus un efektivit\u0101ti vis\u0101 proces\u0101. \u0160\u012b v\u012bzija par ilgtsp\u0113j\u012bbu un efektivit\u0101ti ir atspogu\u013cota ar\u012b cit\u0101s “Olpha” invest\u012bcij\u0101s, piem\u0113ram, saules pane\u013cu parka izb\u016bv\u0113 un laboratoriju inform\u0101cijas vad\u012bbas sist\u0113mas ievie\u0161an\u0101 kvalit\u0101tes kontroles uzlabo\u0161anai. \u0160\u012bs iniciat\u012bvas ne tikai samazina uz\u0146\u0113muma ekolo\u0123isko p\u0113du, bet ar\u012b palielina t\u0101 darb\u012bbas efektivit\u0101ti.<\/p>\n
Strat\u0113\u0123iskie m\u0113r\u0137i un Latvijas farm\u0101cijas nozares loma<\/p>\n
AS “Olpha” ambicioz\u0101 ilgtermi\u0146a att\u012bst\u012bbas strat\u0113\u0123ija paredz kopum\u0101 100 miljonu eiro invest\u012bcijas piecu gadu laik\u0101. \u0160ie l\u012bdzek\u013ci tiks novirz\u012bti produktu portfe\u013ca att\u012bst\u012bbai, ra\u017eo\u0161anas iek\u0101rtu moderniz\u0101cijai, jaudu palielin\u0101\u0161anai jaunu produktu ievie\u0161anai un “za\u013co” tehnolo\u0123isko procesu att\u012bst\u012bbai. Visapjom\u012bg\u0101k\u0101s invest\u012bcijas tiek pl\u0101notas jaunu patentbr\u012bvo z\u0101\u013cu izstr\u0101d\u0113 un eso\u0161\u0101 produktu kl\u0101sta papla\u0161in\u0101\u0161an\u0101. Juris Bundulis uzsver, ka “Olpha” redz sevi k\u0101 viet\u0113jo z\u0101\u013cu ra\u017eot\u0101ju, kuram ir potenci\u0101ls samazin\u0101t Latvijas importa atkar\u012bbu, jo \u0161obr\u012bd aptuveni 95% no Latvij\u0101 pat\u0113r\u0113taj\u0101m z\u0101l\u0113m tiek import\u0113tas. \u0160\u0101da tendence rada augstus riskus pieg\u0101\u017eu p\u0101rr\u0101vumu gad\u012bjumos, apdraudot pacientu vesel\u012bbu. T\u0101p\u0113c ir svar\u012bgi m\u0113r\u0137tiec\u012bgi att\u012bst\u012bt Latvijas farm\u0101cijas un z\u0101\u013cu ra\u017eo\u0161anas nozari, kas Latvij\u0101 ir att\u012bst\u012bta augst\u0101k\u0101 l\u012bmen\u012b nek\u0101 kaimi\u0146valst\u012bs Lietuv\u0101 un Igaunij\u0101. “Olpha” ar sav\u0101m invest\u012bcij\u0101m un skaidru att\u012bst\u012bbas v\u012bziju sniedz b\u016btisku ieguld\u012bjumu \u0161\u012bs nozares stiprin\u0101\u0161an\u0101. Uz\u0146\u0113muma v\u0113sture sniedzas vair\u0101k nek\u0101 50 gadus atpaka\u013c, un tas ir viens no liel\u0101kajiem Baltijas valstu farm\u0101cijas uz\u0146\u0113mumiem. T\u0101 produktu kl\u0101st\u0101 ietilpst vair\u0101k nek\u0101 70 gatav\u0101s z\u0101\u013cu formas un vair\u0101k nek\u0101 20 akt\u012bv\u0101s farmaceitisk\u0101s vielas, kas aptver t\u0101das svar\u012bgas terapeitisk\u0101s grupas k\u0101 neirolo\u0123ija, kardiolo\u0123ija, antibakteri\u0101l\u0101 terapija, onkolo\u0123ija un citas. Uz\u0146\u0113muma produkti tiek eksport\u0113ti uz vair\u0101k nek\u0101 60 valst\u012bm, un tam ir meitasuz\u0146\u0113mumi Francij\u0101, It\u0101lij\u0101, Sp\u0101nij\u0101, V\u0101cij\u0101 un Polij\u0101. \u0160\u012b pla\u0161\u0101 darb\u012bbas joma un starptautiskais sasniegums apliecina “Olpha” potenci\u0101lu un noz\u012bm\u012bgumu glob\u0101laj\u0101 farm\u0101cijas tirg\u016b.<\/p>\n
N\u0101kotnes perspekt\u012bvas un izaicin\u0101jumi<\/p>\n
Latvijas farm\u0101cijas nozare kopum\u0101 ir stabil\u0101 att\u012bst\u012bbas f\u0101z\u0113, neskatoties uz glob\u0101lajiem izaicin\u0101jumiem. Nozaru strat\u0113\u0123ija paredz sasniegt 1,5 miljardu eiro apgroz\u012bjumu z\u0101\u013cu ra\u017eo\u0161anas nozar\u0113 l\u012bdz 2035. gadam, ar fokusu uz eksportsp\u0113jas att\u012bst\u012bbu, efektivit\u0101ti un inov\u0101cij\u0101m. “Olpha” invest\u012bcijas jaun\u0101s iek\u0101rt\u0101s ir tie\u0161i \u0161\u012bs strat\u0113\u0123ijas \u012bsteno\u0161anas piem\u0113rs. Lai gan uz\u0146\u0113muma apgroz\u012bjums un pe\u013c\u0146a pag\u0101ju\u0161aj\u0101 gad\u0101 ir nedaudz samazin\u0101ju\u0161ies, tas ir skaidrojams ar intens\u012bv\u0101m invest\u012bcij\u0101m att\u012bst\u012bb\u0101 un moderniz\u0101cij\u0101. Tiek prognoz\u0113ts, ka \u0161o invest\u012bciju atdeve s\u0101ksies ne \u0101tr\u0101k k\u0101 2026. gad\u0101, kad Eiropas Savien\u012bbas tirgos non\u0101ks arvien vair\u0101k jaunie “Olpha” produkti. Farm\u0101cijas nozare Latvij\u0101 ir sp\u0113jusi izr\u0101d\u012bt savu dz\u012bvotsp\u0113ju un noz\u012bm\u012bgumu, apliecinot sevi k\u0101 vienu no ekonomikas p\u012bl\u0101riem. Ar\u012b “Olpha” sp\u0113l\u0113 svar\u012bgu lomu \u0161aj\u0101 ekosist\u0113m\u0101, ne tikai nodro\u0161inot darba vietas un veicinot ekonomisko izaugsmi, bet ar\u012b palielinot Latvijas z\u0101\u013cu ra\u017eo\u0161anas nozares konkur\u0113tsp\u0113ju starptautisk\u0101 m\u0113rog\u0101. \u0160\u012b invest\u012bcija 4,4 miljonu eiro apm\u0113r\u0101 ir solis uz priek\u0161u, kas stiprin\u0101s uz\u0146\u0113muma poz\u012bcijas un pal\u012bdz\u0113s sasniegt nospraustos strat\u0113\u0123iskos m\u0113r\u0137us.<\/p>\n","protected":false},"excerpt":{"rendered":"\u00abOlpha\u00bb invest\u012bcijas farm\u0101cijas nozar\u0113 sasniegu\u0161as 4,4 miljonus eiro jaunu ra\u017eo\u0161anas iek\u0101rtu moderniz\u0101cij\u0101 Z\u0101\u013cu ra\u017eot\u0101js AS “Olpha” ir veicis…\n","protected":false},"author":2,"featured_media":62900,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[16],"tags":[77,76,16540,790,35,39,38,36,37,34,40,16539,16542,16541],"class_list":{"0":"post-62899","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-bizness","8":"tag-bizness","9":"tag-business","10":"tag-farmacijas-nozare","11":"tag-investicijas","12":"tag-latvia","13":"tag-latvian","14":"tag-latviesu","15":"tag-latviesu-valoda","16":"tag-latviesuvaloda","17":"tag-latvija","18":"tag-lv","19":"tag-olpha","20":"tag-razosanas-modernizacija","21":"tag-zalu-razosana"},"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@lv\/115644381614976857","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/62899","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/comments?post=62899"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/posts\/62899\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media\/62900"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/media?parent=62899"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/categories?post=62899"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/lv\/wp-json\/wp\/v2\/tags?post=62899"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}